Eubel Brady & Suttman Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.9M | Buy |
331,984
+6,639
| +2% | +$579K | 3.66% | 6 |
|
|
2025
Q1 | $29.2M | Buy |
325,345
+1,386
| +0.4% | +$125K | 3.85% | 3 |
|
|
2024
Q4 | $25.9M | Buy |
323,959
+646
| +0.2% | +$51.6K | 3.41% | 6 |
|
|
2024
Q3 | $29.1M | Buy |
323,313
+800
| +0.2% | +$72K | 3.8% | 5 |
|
|
2024
Q2 | $25.4M | Sell |
322,513
-12,072
| -4% | -$950K | 3.67% | 5 |
|
|
2024
Q1 | $29.2M | Sell |
334,585
-2,214
| -0.7% | -$193K | 3.71% | 6 |
|
|
2023
Q4 | $27.7M | Buy |
336,799
+36,851
| +12% | +$3.04M | 3.68% | 4 |
|
|
2023
Q3 | $23.5M | Buy |
299,948
+4,577
| +2% | +$359K | 3.43% | 6 |
|
|
2023
Q2 | $26M | Buy |
295,371
+2,539
| +0.9% | +$224K | 3.59% | 4 |
|
|
2023
Q1 | $23.6M | Buy |
292,832
+286,525
| +4,543% | +$23.1M | 3.42% | 8 |
|
|
2022
Q4 | $490K | Sell |
6,307
-260
| -4% | -$20.2K | 0.08% | 70 |
|
|
2022
Q3 | $530K | Buy |
6,567
+3,509
| +115% | +$283K | 0.09% | 66 |
|
|
2022
Q2 | $274K | Sell |
3,058
-59
| -2% | -$5.29K | 0.05% | 65 |
|
|
2022
Q1 | $346K | Buy |
3,117
+585
| +23% | +$64.9K | 0.06% | 62 |
|
|
2021
Q4 | $262K | Sell |
2,532
-43
| -2% | -$4.45K | 0.05% | 71 |
|
|
2021
Q3 | $323K | Buy |
2,575
+165
| +7% | +$20.7K | 0.07% | 58 |
|
|
2021
Q2 | $285K | Sell |
2,410
-2,410
| -50% | -$285K | 0.02% | 166 |
|
|
2021
Q1 | $570K | Buy |
4,820
+2,423
| +101% | +$287K | 0.06% | 71 |
|
|
2020
Q4 | $281K | Buy |
2,397
+20
| +0.8% | +$2.35K | 0.07% | 67 |
|
|
2020
Q3 | $247K | Buy |
2,377
+31
| +1% | +$3.22K | 0.07% | 65 |
|
|
2020
Q2 | $215K | Buy |
2,346
+84
| +4% | +$7.7K | 0.06% | 70 |
|
|
2020
Q1 | $204K | Buy |
2,262
+22
| +1% | +$1.98K | 0.06% | 69 |
|
|
2019
Q4 | $254K | Buy |
2,240
+383
| +21% | +$43.4K | 0.07% | 68 |
|
|
2019
Q3 | $202K | Buy |
+1,857
| New | +$202K | 0.06% | 71 |
|